Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02810457
Title Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer (AVANA)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Centus Biotherapeutics Limited
Indications

lung non-squamous non-small cell carcinoma

Therapies

Carboplatin + FKB238 + Paclitaxel

Bevacizumab + Carboplatin + Paclitaxel

Age Groups: adult | senior
Covered Countries USA | ITA | ESP | DEU

Additional content available in CKB BOOST